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Abstract – In this study, the mechanism conferring multiple drug resistance in several strains of
ﬂavobacteria isolated from the ovarian ﬂuids of hatchery reared 3-year old brook trout Salvelinus fontinalis
was investigated. Metabolic ﬁngerprinting and 16S rRNA gene sequences identiﬁed the isolates as
Flavobacterium johnsoniae. The isolates exhibited multiple resistances to a wide range of antimicrobial
classes including penicillin, cephem, monobactam, aminoglycoside, and phenicol. Although plasmids and
other transposable elements containing antimicrobial resistance genes were not detected, the isolates did
contain a genomic sequence for a chloramphenicol-inducible resistance-nodulation-division family
multidrug efﬂux pump system. Efﬂux pumps are non-speciﬁc multidrug efﬂux systems. They are also a
component of cell-cell communication systems, and respond speciﬁcally to cell membrane stressors such as
oxidative or nitrosative stress. Understanding of efﬂux pump mediated antibiotic resistances will affect
efﬁcacy of clinical treatments of ﬁshes associated with F. johnsoniae epizootics.
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1. INTRODUCTION
Flavobacterium spp. are Gram-negative,
oxidase-positive, indole-negative, yellow-
pigmented, and non-fermenting rods with glid-
ing motility which are common worldwide in
aquatic environments [6, 23, 38]. Several spe-
cies,includingF. johnsoniae, F. psychrophilum,
F. branchiophilum, and F. columnare, have
been associated with clinical disease in ﬁshes
and represent major threats to commercial
aquaculture [7, 13–15]. Prevention of ﬂavobac-
teria epizootics remains difﬁcult due to the
ubiquitous presence of Flavobacterium spp. in
soils and waters [45, 46]. Therefore, prudent
aquaculturists employ immaculate hygiene,
low ﬁsh densities, and proper feeding rates as
the primary defenses against opportu-
nistic Flavobacterium outbreaks. Short-term,
government approved antimicrobial drugs pro-
vide effective chemotherapy against some
Flavobacterium isolates; however, the identiﬁ-
cation of multidrug resistant (MDR) strains
indicates that the control of disease outbreaks
caused by Flavobacterium spp. will remain a
signiﬁcant challenge [2, 8, 9, 40].
The appropriate choice of effective antimi-
crobial agents for treatment of Flavobacterium
spp. is difﬁcult due to their decreased suscepti-
bility to many antimicrobial agents routinely * Corresponding author: fafekete@colby.edu
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mechanisms for these drug resistances in ﬂavo-
bacteria are not well characterized. We reported
that MDR and mercury resistant Aeromonas
salmonicida in clinically diseased Atlantic
salmon Salmo salar was associated with a con-
jugative Inc A/C plasmid closely resembling
the PSN254 plasmid from the human pathogen
Salmonella enterica [27]. Plasmids have been
reported in Flavobacterium [11, 43] and antimi-
crobial resistance genes have been identiﬁed in
Flavobacterium and Chryseobacterium [3, 11,
18, 37, 43], but the presence of these genes only
partially accounts for the MDR phenotypes
observed in these isolates from diseased salmo-
nids. Intrinsic antibiotic resistance in several
species of Gram-negative bacteria has been
attributed to low permeability of the outer mem-
brane, and to efﬂux pump mechanisms [21, 31,
39]. The contribution of the resistance-nodula-
tion-division (RND) family of antimicrobial
efﬂux pumps to intrinsic antibiotic resistance
hasbeenidentiﬁedinanumberofGram-negative
bacteria,includingBacteroides,Chryseobacteri-
um, Pseudomonas, Salmonella, Campylobacter,
and Vibrio [17, 29, 32–35, 44]. RND multidrug
efﬂuxpumpsarecomposedofatripartitesystem
that includes a cytoplasmic membrane RND
pump, a periplasmic membrane fusion protein,
and an outer membrane protein [34]. Unlike
other systems that confer resistance to speciﬁc
antimicrobial compounds or to classes of antibi-
otics, RND efﬂux pumps are non-speciﬁc
multidrug efﬂux systems. RND efﬂux pumps
arealsoacomponentofcell-cellcommunication
systems, and they respond speciﬁcally to cell
membranestressorssuchasoxidativeornitrosa-
tive compounds [34].
In this study, we identify a chloramphenicol-
inducible RND multidrug efﬂux pump system
in F. johnsoniae. RND efﬂux pump genes
identiﬁed in this study are encoded on the
Flavobacterium spp. chromosome, and not on
mobile genetic elements, such as transposons
or plasmids. This is the ﬁrst report of an
RND multidrug efﬂux pump in the genus
Flavobacterium and is signiﬁcant because
RND pumps can inﬂuence pathogenesis and
can function as virulence determinants in this
ﬁsh pathogen [34].
2. MATERIALS AND METHODS
2.1. Flavobacteria isolate identiﬁcation
Seven ﬂavobacteria isolates were obtained from
the ovarian ﬂuids of 3-year old spawning female
brook trout in Maine, USA, ﬁsh hatcheries. Samples
were collected from females with abnormally cloudy,
coagulating ovarian ﬂuid and less than 20% egg sur-
vival. The isolate designations were P545, P547,
P550, G873, G888, G892, and G899. Flavobacteria
isolates were selected from colonies initially grown
on tryptic soy agar (TSA) plating media (Difco-
BBL, Sparks, MD, USA) at room temperature
(22 C). All pure cultures were Gram-negative,
weakly motile in wet mount preparations, oxidase-
positive, indole-negative, yellow-pigmented, and
non-fermenting rods.
Flavobacteria isolates were further identiﬁed and
characterized from genus to species by the Aquatic
Animal Health Laboratory (University of Maine-
Orono, USA) using the Biolog GN2 MicroPlate Iden-
tiﬁcation System (Biolog, Hayward, CA, USA). Each
isolate was independently identiﬁed by comparing
16S rRNA gene sequence data using F. johnsoniae
17061
T (ATCC 17061) as a positive control. Geno-
mic DNA extraction of all isolates was performed
using the E.Z.N.A.
 Bacterial DNA Kit (Omega
Bio-Tek, Norcross, GA, USA) according to the man-
ufacturer’s instructions. A fragment of the 16S rRNA
gene sequence, approximately 1.3 kb in size, was
ampliﬁed in each strain using the primers 27F and
1392R [20]. Ampliﬁed products were puriﬁed using
the E.Z.N.A. Cycle-Pure Kit (Omega Bio-Tek), and
sequenced using the Big Dye
 Terminator v3.1
C y c l eS e q u e n c i n gK i ta n da nA p p l i e dB i o s y s t e m s
3130 Genetic Analyzer (Foster City, CA, USA). Gen-
Bank database searches (August, 2008) were carried
out for all sequences using the National Center for
Biotechnology Information basic local alignment
search tool (BLAST) web server
1. Multiple sequence
alignments were performed using the ClustalWalign-
ment function of the MacVector 10.0 software pack-
age (MacVector, Inc., Cary, NC, USA) to verify the
strain speciﬁcity of each Flavobacterium isolate.
2.2. Antibiotic susceptibility testing
Antibiotic Minimum Inhibitory Concentrations
(MIC) were determined using the Sensititre
 GN2F
and GPN2F Panel (Trek Diagnostic Systems,
Westlake, OH, USA) dried susceptibility panels.
1 http://www.ncbi.nlm.nih.gov/BLAST.
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exception that isolates were incubated at 22 Cf o r
48 h. Antibiotic MIC assays were done in triplicate
(Tab. I). MIC values were determined as the lowest
concentration of the antimicrobial agent able to inhi-
bit growth. As recommended by Clinical and Labora-
tory Standards Institute and Sensititre
 guidelines
[12], the following reference strains were included
as internal standards: Escherichia coli (ATCC
25922), Pseudomonas aeruginosa (ATCC 27853),
and Enterococcus faecalis (ATCC 29212). Initial test-
ing determined that the MIC value for the efﬂux
pump inhibitor Phenylalanine-Arginine-b-naphthyla-
mide (PabN) (Sigma-Aldrich, St. Louis, MO, USA)
was 200 lg/mL for all strains. A ﬁnal PabNc o n c e n -
tration of 20 lg / m Lw a su s e da si n d i c a t e d( Tab. I).
2.3. Plasmid proﬁling
Plasmid extractions were performed on all isolates
using the Qiagen Plasmid Mini Kit and the Qiagen
Plasmid Midi Kit (Qiagen, Valencia, CA, USA),
according to manufacturer’s instructions and as previ-
o u s l yr e p o r t e d[ 27]. An E. coli DH5-a
TM strain
(Invitrogen, Carlsbad, CA, USA), containing the
pUC19 vector (New England BioLabs
,I p s w i c h ,
MA, USA), was used as the positive plasmid control
and the plasmid-less strain, E. coli DH5-a
TM,w a s
used as the negative control.
2.4. Cloning of antibiotic-resistance genes
and analysis of recombinant plasmids
Genomic DNA was extracted from F. johnsoniae
G873 as described above and partially digested with
Sau3AI (Promega, Madison, WI, USA). Genomic
DNA fragments were ligated into the phagemid
pBK-CMV (Stratagene
, La Jolla, CA, USA), previ-
ously digested with BamHI (New England Bio-
Labs
), and dephosphorylated with calf intestinal
alkaline phosphatase (New England BioLabs
).
Ligations were performed using the Fast-Link
TM
DNA Ligation Kit (Epicentre
 Biotechnologies,
Madison, WI, USA), according to manufacturer’s
instructions. Recombinant plasmids were trans-
formed into E. coli NEB 5-a competent cells (New
England BioLabs
). Antibiotic-resistant colonies
were selected on plates of TSA containing: ampicillin
(16 lg/mL), amikacin (30 lg/mL), gentamycin
(30 lg/mL), kanamycin (30 lg/mL), streptomycin
(30 lg/mL), or chloramphenicol (16 lg/mL). Antibi-
otics were purchased from Sigma-Aldrich. Following
plasmid isolation from resistant clones, vector inserts
were sequenced using the pBK-CMV vector primers
T3 and T7 (Stratagene 2008), designed by Strata-
gene. Sequences were entered into GenBank database
searches (August, 2008) using the BLAST web ser-
ver for identiﬁcation.
2.5. Identiﬁcation of MexB and TonB homologs
A BLAST protein homology search was con-
ducted using the F. johnsoniae 17061
T complete
genomic sequence, submitted to GenBank by the
DOE Joint Genome Institute (CP000685), with the
amino acid sequence of MexB (P. aeruginosa PA01
MexB, accession number NP_249117) as a query.
Matches with a 37% or greater identity were consid-
ered for further analysis.
PCR primers to screen the F. johnsoniae isolates
for the identiﬁed mexB homologs were designed from
the F. johnsoniae UW101 gene sequences using the
Primer 3 software program
2. Additional primers were
designed in the same manner to screen for a gene
encoding a TonB family protein (Fjoh_0490, acces-
sion number YP_01192844) present in F. johnsoniae
UW101. Primers for the corresponding mexA
(Fjoh_4299, accession number YP_001196626) and
oprM (Fjoh_4301, accession number
YP_001196628) homologs of the mexB homolog
Fjoh_4300 (accession number YP_001196627) in
F. johnsoniae UW101 were also designed to screen
the F. johnsoniae isolates. All PCR primers used are
listed in Table II. Following the sequencing of
ampliﬁcation products, sequences were entered in
GenBank database searches (August, 2008) to deter-
mine identity matches, and multiple sequence align-
ments were performed using the ClustalW alignment
function of the MacVector 10.0 software package.
2.6. Quantitative real-time reverse
transcription-PCR (qRT-PCR)
Liquid cultures of F. johnsoniae G873 in 50 mL
LB containing sub-inhibitory concentrations of
chloramphenicol (4 to 8 lg/mL), norﬂoxacin (1 to
3 lg/mL),ampicillin(10 lg/mL)orethidiumbromide
(2 to 50 lg/mL) were statically incubated at room
temperatureovernight. TotalRNAwasextractedusing
the RNeasy
 Protect Bacteria Mini Kit (Qiagen).
Gene expression was quantiﬁed by a one-step real-
time RT-PCR performed on an Applied Biosystems
2 http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_
www.cgi.
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TM Real-Time PCR System (Foster City, CA,
USA) using the QuantiFast SYBR
 Green RT-PCR
Kit(Qiagen).PCRprimersweredesignedasdescribed
above (Tab. II). RNA expression in samples
(100 ng/lg) was normalized using 16S rRNA
(1ng/lL), as done previously for Flavobacterium [16].
Table I. Susceptibility of F. johnsoniae G873 to antimicrobial agents in the absence and presence of
the efﬂux pump inhibitor PabN.
Class MIC (lg/mL)
Antimicrobial agent MIC plate dilution range
(lg/mL)
0 lg/mL PabN2 0 lg/mL PabN
Penicillin
Ampicillin GPN2F (0.12–16) 16 8
Ampicillin/sulbactam GN2F (4/2–32/16) 16/8 8/4
Oxacillin + 2% NaCl GPN2F (0.25–8) 0.25 0.25
Penicillin GPN2F (0.06–8) 8 4
Cephem
Cefazolin GN2F (4–32) > 32 > 32
Cefepime GN2F (4–32) 8 8
Ceftazidime GN2F (1–32) > 32 > 32
Macrolide
Erythromycin GPN2F (0.25–8) 4 0.5
*
Clarithromycin GPN2F (1–8) 1 1
Monobactam
Aztreonam GN2F (8–32) > 32 > 32
Lincosamide
Clindamycin GPN2F (0.5–4) 0.5 0.5
Fluoroquinolone
Levoﬂoxacin GPN2F (0.25–8) 1 0.25
*
Oxazolidinone
Linezolid GPN2F (0.5–8) 4 1
*
Streptogramin
Quinupristin/dalfopristin GPN2F (0.25–4) > 4 4
Ansamycin
Rifampin GPN2F (0.5–4) 0.5 0.5
Tetracycline
Tetracycline GPN2F (2–16) 2 2
Aminoglycoside
Amikacin Dilution assay 140 100
Gentamicin Dilution assay 140 100
Kanamycin Dilution assay 450 400
Streptomycin Dilution assay 64 32
Phenicol
Chloramphenicol Dilution assay 16 4
*
Florfenicol Dilution assay 16 4
*
Flouroquinolone
Nalidixic acid Dilution assay 140 140
Norﬂoxacin Dilution assay 4 1
*
* Four-fold MIC decrease; GPN2F Trek Diagnostic Systems Sensititre Gram-Positive MIC Plate; GN2F Trek
Diagnostic Systems Sensititre Gram-Negative MIC Plate.
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The nucleotide sequences reported in this paper
have been assigned to GenBank databases and
assigned accession numbers EU984145-EU984170
and EU984179-EU984187.
3. RESULTS
3.1. Flavobacterium spp. identiﬁcation
All Flavobacterium isolates, except P547,
were identiﬁed as 100% probability matches
to F. johnsoniae through metabolic ﬁngerprint-
ing using the Biolog GN2 MicroPlate Identiﬁ-
cation System. Isolate P547 was identiﬁed as
F. johnsoniae, however the probability could
not be determined because this isolate’s meta-
bolic ﬁngerprint also closely matched the
ﬁngerprint of F. hydatis.
The 1.3 kb 16S rRNA gene sequences for all




F. johnsoniae and F. hydatis are very closely
related phylogenetically and almost impossible
to discriminate, even by genomic approaches.
Based on the Biolog GN2 results and 16SrRNA
gene sequence data, the ﬂavobacteria isolates
were presumptively identiﬁed as F. johnsoniae.
3.2. Antimicrobial susceptibility
Antibiotic susceptibility testing indicated
multidrug resistance proﬁles for all F. johnso-
niae isolates were similar. F. johnsoniae G873
isolate for example, showed susceptibility to
oxacillin + 2% NaCl, clarithromycin, clindamy-
cin, rifampin, and tetracycline, and resistance to
cefazolin, ceftazidime, aztreonam, quinupristin/
Table II. Primers used in this study were designed from F. johnsoniae 17061
T. All Fjoh primers are based
on the mexB homolog sequences with the exception of Fjoh_4299 and Fjoh_4301, which are based on the
mexA and oprM homolog sequences.
Name Sequence Target Reference
27F AGAGTTTGATCCTGGCTCAG 16S rRNA [20]
1392R GACGGGCGGTGTGTAC 16S rRNA [20]
16SR TAGCACGTGTGTAGCCCAAG 16S rRNA, for qRT-PCR This study
16SF CGCAACCCCTGTTGTTAGTT 16S rRNA, for qRT-PCR This study
T3 AATTAACCCTCACTAAAGG PBK-CMV plasmid insert [41]
T7 GTAATACGACTCACTATAGGGC PBK-CMV plasmid insert [41]
0907R TCAGGCACCGTCAAATTGTA Fjoh_0907 This study
0907F TTTGGCGCGTATAAAAGGAG Fjoh_0907 This study
4131R AAGAAGCCCGATAAGCATGA Fjoh_4131 This study
4131F TCGATTCCGTTTGGATTAGC Fjoh_4131 This study
4300R CCATTTCGCCTGTTTTGTTT Fjoh_4300 This study
4300F1 CGCACAGGCATCTGACTTTA Fjoh_4300 This study
4300F2 CCAACTGTTCCCGGATTTAG Fjoh_4300 This study
4299R TGTCAAGGTTTCCGCTTACC Fjoh_4299 This study
4299F TCCCGAGAATGCCAGAATAC Fjoh_4299 This study
4301R TTGCTTGTGCTTGCGTTTAC Fjoh_4301 This study
4301F AACCAAAATCGTGACCTTCG Fjoh_4301 This study
3239R CAGAATCGTTCCGTCTGGAT Fjoh_3239 This study
3239F GATCCGGACAGCTTGACAAT Fjoh_3239 This study
4862R GCACTTTGTGCGATGATGTT Fjoh_4862 This study
4862F CGATTTTGGCCAATACATTT Fjoh_4862 This study
CFLR ACAGCTTCCGATAGCCTGAA Cﬂ/Bcr efﬂux pump This study
CFLF AACCGCTCTTGGTCCTTTTT Cﬂ/Bcr efﬂux pump This study
Multidrug efﬂux pump in F. johnsoniae Vet. Res. (2009) 40:55
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(Tab. I). Susceptibility data of other isolates
are not shown because they were similar. Isolate
G873 was selected for subsequent antimicrobial
susceptibility testing with PabN. The remaining
isolates were archived.
3.3. Identiﬁcation of genomic antimicrobial
resistance genes
Plasmids were not detectable in any of the
F. johnsoniae isolates. An initial attempt to
determine the presence of antibiotic-resistance
genes in the F. johnsoniae isolates utilized
genomic libraries, which, following construc-
tion, were used to screen for antibiotic-resis-
tance determinants. Antibiotic selection of the
genomic library of strain F. johnsoniae G873
resulted in the growth of an amikacin-resistant
clone. When sequenced, this clone encoded a
sequence with an 85% identity match to the
nucleotide sequence of a gene encoding a
TonB-dependent receptor in F. johnsoniae
UW101 (Fjoh_1451, accession number
YP_001193802). In order to verify the presence
of tonB in F. johnsoniae G873 as well as in the
other F. johnsoniae isolates, a partial nucleotide
sequence for a gene that encodes a TonB family
protein in F. johnsoniae UW101 (Fjoh_0490,
accession number YP_01192844) was ampli-
ﬁed in all isolates.
3.4. MexB RND efﬂux pump homologs
in F. johnsoniae isolates
Genomic analysis of F. johnsoniae UW101
resulted in the identiﬁcation of seven P. aeru-
ginosa PA01 MexB RND efﬂux pump homo-
log proteins with 37–41% sequence similarity.
These MexB homologs include Fjoh_4300
(accession number YP_001196627), Fjoh_4131
(accession number YP_00119648), Fjoh_3239
(accession number YP_001195574), Fjoh_4862
(accession number YP_001197180), Fjoh_0907
(accession number YP_001193260), Fjoh_4408
(accession number YP_001196733), and
Fjoh_3227 (accession number YP_001195563).
Interestingly, each of the mexB homologs
was associated with mexA and oprM homo-
logs in the same gene arrangement as the
mexAB-oprM operon. Partial genetic regions
of ﬁve of these mexB homologs, including
Fjoh_4300, Fjoh_4131, Fjoh_3239, Fjoh_4862,
and Fjoh_0907, were successfully ampliﬁed in
F. johnsoniae G873. The primer sets for these
sequences were subsequently used for the
qRT-PCR experiments (Tab. II).
3.5. Chloramphenicol induction of fmeB1
expression
qRT-PCR was used to measure relative
expression of the ﬁve mexB homologs identi-
ﬁed in F. johnsoniae G873 following exposure
to sub-inhibitory concentrations of the follow-
ing antimicrobial compounds and cytotoxic
agents: chloramphenicol, norﬂoxacin, ampicil-
lin, and ethidium bromide. It was found that
exposure to 8 lg/mL chloramphenicol resulted
in an increase in the expression of the mexB
homolog Fjoh_4300, which we named fmeB1,
in F. johnsoniae G873 (Fig. 1). This mexB
homolog and the corresponding putative RND
multidrug efﬂux pump system were hereby
named FmeABC1. Exposure to ampicillin, nor-
ﬂoxacin, or ethidium bromide did not result in
any signiﬁcant change in fmeB1 expression
(Fig. 1). For all other mexB homologs in
F. johnsoniae G873, there were no signiﬁcant
changes in expression due to exposure to any
of the potential efﬂux pump substrates tested.
Following the qRT-PCR results, an approxi-
mately 350-bp partial sequence of the fmeB1
gene was ampliﬁed in all seven F. johnsoniae
isolates. A clustal alignment of the amino acid
sequences of FmeB1, Fjoh_4300, and MexB
is shown in Figure 2. Partial sequences of the
corresponding mexA homolog, fmeA1,w e r e
also ampliﬁed in all F. johnsoniae isolates (data
not shown). The corresponding oprM homolog,
fmeC1, was not successfully ampliﬁed in any of
the F. johnsoniae isolates (data not shown).
3.6. Antibiotic MIC reduction with PabN
The effect of the efﬂux pump inhibitor PabN
on the MIC values for a wide range of antibiot-
ics was tested in F. johnsoniae G873 (Tab. I).
A MIC decrease of four-fold or more in the
Vet. Res. (2009) 40:55 S.E. Clark et al.
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phenicol, ﬂorfenicol, norﬂoxacin, erythromy-
cin, levoﬂoxacin, linezoid, nitrofurantoin, and
trimethoprim with sulfamethoxazole. These
data provide phenotypic evidence for the pres-
ence of multiple substrates of efﬂux pumps in
the F. johnsoniae isolates.
4. DISCUSSION
Classiﬁcation of Flavobacterium species is
complex, and often requires multiple identiﬁca-
tion methods for speciation of environmental
isolates [5, 15] .T h ei s o l a t e su s e di nt h i ss t u d y




Ethidium bromide (2 µg/mL)
Norfloxacin (3 µg/mL)
fmeB1 expression 
Figure 1. Semi-log bar graph illustrating the relative expression of mexB homolog Fjoh_4300 hereafter
named fmeB1. Quantitative real time RT-PCR compared expression of fmeB1 in F. johnsoniae G873 with
exposure to antibiotic compounds norﬂoxacin, chloramphenicol and ampicillin and cytotoxic compound
ethidium bromide.
Figure 2. ClustalW alignment of amino acid sequences for MexB, (P. aeruginosa PA01), Fjoh_4300,
(F. johnsoniae 17061
T), and FmeB1, (F. johnsoniae G873). Boxed, shaded residues indicate identical or
similar amino acid sequences.
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and 16S rRNA gene sequence determinations.
These isolates were obtained from cultured
brook trout. There have been relatively few
studies linking F. johnsoniae with ﬁsh infec-
tious disease [10, 15, 36], and the isolation of
these F. johnsoniae isolates from clinical speci-
mens represents additional evidence that this
species is a putative opportunistic Flavobacte-
rium pathogen.
Pathogenic Flavobacterium spp. represent
a major threat to commercial and resto-
ration aquaculture and the prevalence of MDR
isolates demonstrates a growing need to
advance our understanding of the antibiotic-
resistance mechanisms of these bacteria
[1, 9, 29]. The antibiotic-resistance determi-
nants of Flavobacterium,a sw e l la st h e i r
close phylogenetic relatives Chryseobacterium,
remain largely unresolved, likely due to the lack
of available genetic tools [25, 42]. Of the b-
lactamase genes that have been identiﬁed, many
are distantly related to other b-lactamase genes
or form new enzyme subclasses [4, 30]. Several
of these b-lactamase genes were isolated by
screening genomic libraries for antibiotic-
resistant clones. Following initial unsuccessful
attempts to identify antibiotic-resistance genes
in the MDR F. johnsoniae isolates using prim-
ers from the literature for various classes of
antibiotic-resistance determinants, genomic
libraries of several strains were constructed
(Tab. II). Screening of a genomic library made
from isolate F. johnsoniae G873 resulted in the
discovery of an amikacin-resistant clone con-
taining a partial sequence of a gene encoding
a TonB-dependent receptor protein. TonB
enhances the resistance of the MexAB-OprM
efﬂux system in P. aeruginosa [47]. Because
of the previously established connection
between TonB and RND multidrug efﬂux
pumps, in addition to the failure to identify
alternative antibiotic-resistance genes, the con-
tribution of RND efﬂux pumps to the antibiotic
resistance of the F. johnsoniae isolates was
investigated. The presence of multidrug efﬂux
pumps was also considered because RND mul-
tidrug efﬂux pumps are typically located on the
bacterial chromosome, and plasmids were not
detectable in these isolates.
Phenotypic evidence for the presence of
functional RND multidrug efﬂux pumps was
obtained using the efﬂux pump inhibitor
PabN. PabN was originally identiﬁed in a
screen for a broad-spectrum inhibitor of the
P. aeruginosa Mex efﬂux pumps, and works
as a competitive inhibitor of these and other
similar RND multidrug efﬂux pumps [22,
28]. PabN has been used in several investiga-
tions to screen for the presence of efﬂux
pumps, often in clinical isolates [19, 24, 28].
In this study, the effect of PabNo nM I Cv a l -
ues for a wide range of antimicrobial agents
was tested in F. johnsoniae G873 (Tab. I).
A four-fold or greater MIC decrease in the
presence of PabN was detected for a number
of antibiotics, including chloramphenicol and
ﬂorfenicol. The identiﬁcation of ﬂorfenicol as
a putative efﬂux pump substrate is important
for aquaculture, because it is used for
treatment of ﬁsh disease outbreaks [26]. These
results reﬂect a similar reduction in
ﬂorfenicol MIC values due to PabNi n
Chryseobacterium [29], implying that efﬂux
pump mediated ﬂorfenicol resistance is not
exclusive to F. johnsoniae. Also, the PabN
reduction of chloramphenicol resistance com-
plements the ﬁnding that chloramphenicol
induces expression of fmeB1 (Fig. 1). The
remaining antimicrobials with decreased MIC
values as a result of PabN inhibition provide
phenotypic evidence for the presence of multi-
ple possible efﬂux pump substrates.
In conclusion, this study represents the iden-
tiﬁcation and initial characterization of an RND
multidrug efﬂux pump system, hereby named
FmeABC1, in F. johnsoniae.T h i sn o m e n c l a -
ture follows the convention established by Ueda
et al. for newly identiﬁed Mex efﬂux pump sys-
tem homologs in Bacteroides [40]. The expres-
sion of fmeB1,1o f5mexB homologs identiﬁed
in F. johnsoniae G873, was induced by expo-
sure to chloramphenicol. These data demon-
strate that there may be multiple efﬂux pump
substrates in speciﬁc strains of F. johnsoniae.
The contribution of efﬂux pump mediated anti-
biotic resistances should be factored into deci-
sions regarding the efﬁcacy of clinical
treatments of ﬁshes associated with ﬂavobacte-
ria epizootics.
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